A method of effecting regression of atherosclerotic disease in a patient whose plasma lipid concentrations are at levels considered normal or optimal. The method involves treating the patient with a combination of a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor and niacin. Disease regression has been observed over periods as short as 14 months, preferably 8 months.
Ruby on Rails Smalltalk MySQL Dynamic Languages Tomcat Struts JSP Eclipse PL/SQL C# Linux UML Spring Unix Shell Scripting Python Subversion Weblogic Web Services Databases OOP Perl Websphere Software Development Ruby XML Scrum Unix HTML Groovy Java Enterprise Edition JUnit Java Oracle Web Applications SOAP Integration Visual Studio Hibernate jQuery REST SOA C++ Apache CVS SQL AJAX DB2 Agile Methodologies Ant PHP
Dr. Taylor graduated from the Johns Hopkins University School of Medicine in 1988. He works in Washington, DC and specializes in Cardiovascular Disease. Dr. Taylor is affiliated with Medstar Georgetown University Hospital.
Adams County, PennsylvaniaOwner at self employed I am a full-time Internet marketer and poet. Spent 2005 in Iraq (pretty much against my will) and am compiling a book of poems based on that experience. I live... I am a full-time Internet marketer and poet. Spent 2005 in Iraq (pretty much against my will) and am compiling a book of poems based on that experience. I live with my beautiful, but crazy wife, and three rambunctious grandchildren.